Clinical Breast Cancer

Published by: Elsevier Inc.  

People

  1. Hudis
    Hudis
  2. Seidman
    Seidman
  3. Norton
    Norton
  4. D'Andrea-Carlino
    D'Andrea-Carlino
  5. Fornier
    Fornier
  6. Modi
    Modi
  7. Dang
    Dang
  8. Lake
    Lake
  9. Traina
    Traina
  10. Sugarman
    Sugarman

Groups

  1. Department of Medicine (50)
  2. Solid Tumor Oncology Division (49)
  3. Breast Medicine Service (48)
  4. Survivorship Research (39)
  5. Epidemiology and Biostatistics (13)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  7. Biostatistics Service (12)
  8. GSK Faculty (9)
  9. Population Sciences Research Program (8)
  10. Radiology, Department of (7)
Search Within
Formats
  1. Journal Article (62)
  2. Review (7)
Groups
  1. Department of Medicine (50)
  2. Solid Tumor Oncology Division (49)
  3. Breast Medicine Service (48)
  4. Survivorship Research (39)
  5. Epidemiology and Biostatistics (13)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)

More Groups

People
  1. Clifford Hudis (26)
  2. Andrew Seidman (19)
  3. Larry Norton (10)
  4. Sujata Patil (10)
  5. Gabriella D'Andrea-Carlino (8)
  6. Monica Fornier (8)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publishers
  1. Elsevier Inc. (69)

Results (69)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing postneoadjuvant treatment of residual breast cancer with adjuvant bevacizumab alone, with metronomic or standard-dose chemotherapy: A combined analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE clinical trials
    Journal Article

    Trapani, D.; Jin, Q.; Miller, K. D.; Rugo, H. S.; Reeder-Hayes, K. E.; Traina, T.; Abdou, Y.; Falkson, C.; Abramson, V.; Ligibel, J.; more...
    Clinical Breast Cancer (2025)

    Fulltext@MSK | Save
  • Effects of lasofoxifene versus fulvestrant on vaginal and vulvar symptoms in patients with ESR1-mutated, ER+/HER2-, metastatic breast cancer from the ELAINE 1 study
    Journal Article

    Goldfarb, S. B.; Sammons, S. L.; Meisel, J. L.; Pluard, T. J.; Jenkins, S. N.; Komm, B. S.; Carroll, D.; Portman, D. J.
    Clinical Breast Cancer (2025)

    Fulltext@MSK | Save
  • New strategies for locally advanced breast cancer: A Review of inflammatory breast cancer and nonresponders
    Review

    Malhotra, S.; Tadros, A. B.
    Clinical Breast Cancer (2024)

    Fulltext@MSK | Save
  • Systemic therapy advances for HER2-positive and triple negative breast cancer: What the surgeon needs to know
    Review

    Downs-Canner, S.; Weiss, A.
    Clinical Breast Cancer (2024)

    Fulltext@MSK | Save
  • Clinical and imaging features of MRI screen-detected breast cancer
    Journal Article

    Ghuman, N.; Ambinder, E. B.; Oluyemi, E. T.; Sutton, E.; Myers, K. S.
    Clinical Breast Cancer (2024)

    Fulltext@MSK | Save
  • Molecularly targeted therapies for triple negative breast cancer: History, advances, and future directions
    Review

    Mai, N.; Abuhadra, N.; Jhaveri, K.
    Clinical Breast Cancer (2023)

    Fulltext@MSK | Save
  • Metaplastic breast cancer: Current understanding and future directions
    Review

    Thomas, A.; Douglas, E.; Reis-Filho, J. S.; Gurcan, M. N.; Wen, H. Y.
    Clinical Breast Cancer (2023)

    Fulltext@MSK | Save
  • Are we overtreating patients with T1(a) HER2+ breast cancer? An Analysis of the National Cancer Database
    Journal Article

    Williams, A. D.; Solis, O.; Sterbling, H. M.; Murray, A.; Sogunro, O.; De La Cruz, L. M.
    Clinical Breast Cancer (2022)

    Fulltext@MSK | Save
  • Olaparib use in patients with metastatic breast cancer harboring somatic BRCA1/2 mutations or mutations in non-BRCA1/2, DNA damage repair genes
    Journal Article

    Walsh, E. M.; Mangini, N.; Fetting, J.; Armstrong, D.; Chan, I. S.; Connolly, R. M.; Fiallos, K.; Lehman, J.; Nunes, R.; Petry, D.; more...
    Clinical Breast Cancer (2022)

    Fulltext@MSK | Save
  • Tumor immune microenvironment and response to neoadjuvant chemotherapy in hormone receptor/HER2+ early stage breast cancer
    Journal Article

    Vanguri, R. S.; Fenn, K. M.; Kearney, M. R.; Wang, Q.; Guo, H.; Marks, D. K.; Chin, C.; Alcus, C. F.; Thompson, J. B.; Leu, C. S.; more...
    Clinical Breast Cancer (2022)

    Fulltext@MSK | Save

    • Clinical Breast Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Clinical Breast Cancer 15268209 Unknown
    Clinical Breast Cancer 15268209 Elsevier Inc.
    Clinical Breast Cancer 15268209 The Authors
    Clinical Breast Cancer 1526-8209 Elsevier Inc.
    Clinical Breast Cancer 15268209 2022
    Clinical Breast Cancer 1526-8209 Elsevier Inc.
    Clinical Breast Cancer 19380666 2011
    Clinical Breast Cancer 1526-8209 Cig Media Group, Lp
    Clinical Breast Cancer 1526-8209 Unknown
    Clinical breast cancer 19380666 Unknown
    Clinical Breast Cancer 15268209 2024